Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor‐dependent, transcription‐independent mechanism

Recruitment to activated tyrosine kinase growth factor receptors of Grb2 and p21ras leads to downstream activation of the kinases Raf, MAPK/Erk kinase (Mek) and, subsequently, extracellular signal‐regulated kinase (Erk). Activated Erk phosphorylates specific serine residues within cytosolic phosphol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of pharmacology 2000-05, Vol.130 (2), p.289-298
Hauptverfasser: Croxtall, Jamie D, Choudhury, Qam, Flower, Rod J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 298
container_issue 2
container_start_page 289
container_title British journal of pharmacology
container_volume 130
creator Croxtall, Jamie D
Choudhury, Qam
Flower, Rod J
description Recruitment to activated tyrosine kinase growth factor receptors of Grb2 and p21ras leads to downstream activation of the kinases Raf, MAPK/Erk kinase (Mek) and, subsequently, extracellular signal‐regulated kinase (Erk). Activated Erk phosphorylates specific serine residues within cytosolic phospholipase A2 (PLA2), promoting enzyme translocation to membranes and facilitating liberation of arachidonic acid (AA). In the A549 human adenocarcinoma cell line dexamethasone inhibited epidermal growth factor (EGF)‐stimulated cytosolic PLA2 (cPLA2) activation and AA release by blocking the recruitment of Grb2 to the activated EGF receptor (EGF‐R) through a glucocorticoid receptor (GR)‐dependent (RU486‐sensitive), transcription‐independent (actinomycin‐insensitive), mechanism. The dexamethasone‐induced block of Grb2 recruitment was parallelled by changes in phosphorylation status and subcellular localization of lipocortin 1 (LC1) and an increase in the amount of the tyrosine phosphoprotein co‐localized with EGF‐R. Like dexamethasone, peptides containing E‐Q‐E‐Y‐V from the N‐terminal domain of LC1 also blocked ligand‐induced association of Grb2, p21ras and Raf. Our results point to an unsuspected rapid effect of glucocorticoids, mediated by occupation of GR but not by changes in gene transcription, which is brought about by competition between LC1 and Grb2 leading to a failure of recruitment off signalling factors to EGF‐R British Journal of Pharmacology (2000) 130, 289–298; doi:10.1038/sj.bjp.0703272
doi_str_mv 10.1038/sj.bjp.0703272
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1572055</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1024061501</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4578-e7555f475b624554cdb0c65053e7f8068da5cdb3e5f671a884892d6361e2f9a83</originalsourceid><addsrcrecordid>eNqFksFu1DAQhiMEokvhyhFZHDg1ix3HsfeCVKp2i1QJDnC2HMfZTJTYwXZa9cYj8Ch9Jp4EL1mtChdOtub_5tevmcmy1wSvCabifejXdT-tMce04MWTbEVKXuWMCvI0W2GMeU6IECfZixB6jJPI2fPshGCBeVWxVfawHWbttPMRtIMmIKUjuoPYgUUj2DmagKJDYDuoISJvtJ8hjsZG5FoUYGfVMIDdoTY1Ov8HTj-4VdE06HJ7tW8x0yJ13s27Dqlj7dePn42ZjG2S3xmKXtmgPUwRnE0S2KOIRqM7ZSGML7NnrRqCeXV4T7NvV5dfL67zm8_bTxfnN7kuGRe54YyxtuSsroqSsVI3NdYVw4wa3gpciUaxVKOGtRUnSohSbIqmohUxRbtRgp5mHxbfaa5H0-gUwqtBTh5G5e-lUyD_Vix0cuduJWG8wIwlg3cHA---zyZEOULQZhiUNW4OkhOCCeYkgW__AXs3-zTXIAvCSdoY3UPrBdLeheBNe0xCsNxfggy9TJcgD5eQGt48zv8IX1afALoAdzCY-__YyY9frgndCPobSfLH_g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217177531</pqid></control><display><type>article</type><title>Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor‐dependent, transcription‐independent mechanism</title><source>MEDLINE</source><source>Wiley Online Library Free Content</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Croxtall, Jamie D ; Choudhury, Qam ; Flower, Rod J</creator><creatorcontrib>Croxtall, Jamie D ; Choudhury, Qam ; Flower, Rod J</creatorcontrib><description>Recruitment to activated tyrosine kinase growth factor receptors of Grb2 and p21ras leads to downstream activation of the kinases Raf, MAPK/Erk kinase (Mek) and, subsequently, extracellular signal‐regulated kinase (Erk). Activated Erk phosphorylates specific serine residues within cytosolic phospholipase A2 (PLA2), promoting enzyme translocation to membranes and facilitating liberation of arachidonic acid (AA). In the A549 human adenocarcinoma cell line dexamethasone inhibited epidermal growth factor (EGF)‐stimulated cytosolic PLA2 (cPLA2) activation and AA release by blocking the recruitment of Grb2 to the activated EGF receptor (EGF‐R) through a glucocorticoid receptor (GR)‐dependent (RU486‐sensitive), transcription‐independent (actinomycin‐insensitive), mechanism. The dexamethasone‐induced block of Grb2 recruitment was parallelled by changes in phosphorylation status and subcellular localization of lipocortin 1 (LC1) and an increase in the amount of the tyrosine phosphoprotein co‐localized with EGF‐R. Like dexamethasone, peptides containing E‐Q‐E‐Y‐V from the N‐terminal domain of LC1 also blocked ligand‐induced association of Grb2, p21ras and Raf. Our results point to an unsuspected rapid effect of glucocorticoids, mediated by occupation of GR but not by changes in gene transcription, which is brought about by competition between LC1 and Grb2 leading to a failure of recruitment off signalling factors to EGF‐R British Journal of Pharmacology (2000) 130, 289–298; doi:10.1038/sj.bjp.0703272</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1038/sj.bjp.0703272</identifier><identifier>PMID: 10807665</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>A549 cells ; Adaptor Proteins, Signal Transducing ; annexin 1 ; Annexin A1 - biosynthesis ; Annexin A1 - metabolism ; Binding, Competitive ; Dexamethasone - pharmacology ; Enzyme Activation ; epidermal growth factor ; epidermal growth factor receptors ; glucocorticoids ; Glucocorticoids - pharmacology ; Grb2 ; GRB2 Adaptor Protein ; Humans ; Lipocortin 1 ; MAP Kinase Signaling System - physiology ; mitogen‐activated protein kinase ; phospholipase A2 ; Phospholipases A - metabolism ; Phosphorylation - drug effects ; Protein Conformation ; Proteins - chemistry ; Proteins - metabolism ; Receptor, Epidermal Growth Factor - metabolism ; Receptors, Glucocorticoid - metabolism ; Signal Transduction - drug effects ; Signal Transduction - physiology ; Transcription, Genetic ; Tumor Cells, Cultured</subject><ispartof>British journal of pharmacology, 2000-05, Vol.130 (2), p.289-298</ispartof><rights>2000 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group May 2000</rights><rights>Copyright 2000, Nature Publishing Group 2000 Nature Publishing Group</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4578-e7555f475b624554cdb0c65053e7f8068da5cdb3e5f671a884892d6361e2f9a83</citedby><cites>FETCH-LOGICAL-c4578-e7555f475b624554cdb0c65053e7f8068da5cdb3e5f671a884892d6361e2f9a83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572055/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572055/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,1417,1433,27924,27925,45574,45575,46409,46833,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10807665$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Croxtall, Jamie D</creatorcontrib><creatorcontrib>Choudhury, Qam</creatorcontrib><creatorcontrib>Flower, Rod J</creatorcontrib><title>Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor‐dependent, transcription‐independent mechanism</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>Recruitment to activated tyrosine kinase growth factor receptors of Grb2 and p21ras leads to downstream activation of the kinases Raf, MAPK/Erk kinase (Mek) and, subsequently, extracellular signal‐regulated kinase (Erk). Activated Erk phosphorylates specific serine residues within cytosolic phospholipase A2 (PLA2), promoting enzyme translocation to membranes and facilitating liberation of arachidonic acid (AA). In the A549 human adenocarcinoma cell line dexamethasone inhibited epidermal growth factor (EGF)‐stimulated cytosolic PLA2 (cPLA2) activation and AA release by blocking the recruitment of Grb2 to the activated EGF receptor (EGF‐R) through a glucocorticoid receptor (GR)‐dependent (RU486‐sensitive), transcription‐independent (actinomycin‐insensitive), mechanism. The dexamethasone‐induced block of Grb2 recruitment was parallelled by changes in phosphorylation status and subcellular localization of lipocortin 1 (LC1) and an increase in the amount of the tyrosine phosphoprotein co‐localized with EGF‐R. Like dexamethasone, peptides containing E‐Q‐E‐Y‐V from the N‐terminal domain of LC1 also blocked ligand‐induced association of Grb2, p21ras and Raf. Our results point to an unsuspected rapid effect of glucocorticoids, mediated by occupation of GR but not by changes in gene transcription, which is brought about by competition between LC1 and Grb2 leading to a failure of recruitment off signalling factors to EGF‐R British Journal of Pharmacology (2000) 130, 289–298; doi:10.1038/sj.bjp.0703272</description><subject>A549 cells</subject><subject>Adaptor Proteins, Signal Transducing</subject><subject>annexin 1</subject><subject>Annexin A1 - biosynthesis</subject><subject>Annexin A1 - metabolism</subject><subject>Binding, Competitive</subject><subject>Dexamethasone - pharmacology</subject><subject>Enzyme Activation</subject><subject>epidermal growth factor</subject><subject>epidermal growth factor receptors</subject><subject>glucocorticoids</subject><subject>Glucocorticoids - pharmacology</subject><subject>Grb2</subject><subject>GRB2 Adaptor Protein</subject><subject>Humans</subject><subject>Lipocortin 1</subject><subject>MAP Kinase Signaling System - physiology</subject><subject>mitogen‐activated protein kinase</subject><subject>phospholipase A2</subject><subject>Phospholipases A - metabolism</subject><subject>Phosphorylation - drug effects</subject><subject>Protein Conformation</subject><subject>Proteins - chemistry</subject><subject>Proteins - metabolism</subject><subject>Receptor, Epidermal Growth Factor - metabolism</subject><subject>Receptors, Glucocorticoid - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>Signal Transduction - physiology</subject><subject>Transcription, Genetic</subject><subject>Tumor Cells, Cultured</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFksFu1DAQhiMEokvhyhFZHDg1ix3HsfeCVKp2i1QJDnC2HMfZTJTYwXZa9cYj8Ch9Jp4EL1mtChdOtub_5tevmcmy1wSvCabifejXdT-tMce04MWTbEVKXuWMCvI0W2GMeU6IECfZixB6jJPI2fPshGCBeVWxVfawHWbttPMRtIMmIKUjuoPYgUUj2DmagKJDYDuoISJvtJ8hjsZG5FoUYGfVMIDdoTY1Ov8HTj-4VdE06HJ7tW8x0yJ13s27Dqlj7dePn42ZjG2S3xmKXtmgPUwRnE0S2KOIRqM7ZSGML7NnrRqCeXV4T7NvV5dfL67zm8_bTxfnN7kuGRe54YyxtuSsroqSsVI3NdYVw4wa3gpciUaxVKOGtRUnSohSbIqmohUxRbtRgp5mHxbfaa5H0-gUwqtBTh5G5e-lUyD_Vix0cuduJWG8wIwlg3cHA---zyZEOULQZhiUNW4OkhOCCeYkgW__AXs3-zTXIAvCSdoY3UPrBdLeheBNe0xCsNxfggy9TJcgD5eQGt48zv8IX1afALoAdzCY-__YyY9frgndCPobSfLH_g</recordid><startdate>200005</startdate><enddate>200005</enddate><creator>Croxtall, Jamie D</creator><creator>Choudhury, Qam</creator><creator>Flower, Rod J</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200005</creationdate><title>Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor‐dependent, transcription‐independent mechanism</title><author>Croxtall, Jamie D ; Choudhury, Qam ; Flower, Rod J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4578-e7555f475b624554cdb0c65053e7f8068da5cdb3e5f671a884892d6361e2f9a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>A549 cells</topic><topic>Adaptor Proteins, Signal Transducing</topic><topic>annexin 1</topic><topic>Annexin A1 - biosynthesis</topic><topic>Annexin A1 - metabolism</topic><topic>Binding, Competitive</topic><topic>Dexamethasone - pharmacology</topic><topic>Enzyme Activation</topic><topic>epidermal growth factor</topic><topic>epidermal growth factor receptors</topic><topic>glucocorticoids</topic><topic>Glucocorticoids - pharmacology</topic><topic>Grb2</topic><topic>GRB2 Adaptor Protein</topic><topic>Humans</topic><topic>Lipocortin 1</topic><topic>MAP Kinase Signaling System - physiology</topic><topic>mitogen‐activated protein kinase</topic><topic>phospholipase A2</topic><topic>Phospholipases A - metabolism</topic><topic>Phosphorylation - drug effects</topic><topic>Protein Conformation</topic><topic>Proteins - chemistry</topic><topic>Proteins - metabolism</topic><topic>Receptor, Epidermal Growth Factor - metabolism</topic><topic>Receptors, Glucocorticoid - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>Signal Transduction - physiology</topic><topic>Transcription, Genetic</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Croxtall, Jamie D</creatorcontrib><creatorcontrib>Choudhury, Qam</creatorcontrib><creatorcontrib>Flower, Rod J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Croxtall, Jamie D</au><au>Choudhury, Qam</au><au>Flower, Rod J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor‐dependent, transcription‐independent mechanism</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2000-05</date><risdate>2000</risdate><volume>130</volume><issue>2</issue><spage>289</spage><epage>298</epage><pages>289-298</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><abstract>Recruitment to activated tyrosine kinase growth factor receptors of Grb2 and p21ras leads to downstream activation of the kinases Raf, MAPK/Erk kinase (Mek) and, subsequently, extracellular signal‐regulated kinase (Erk). Activated Erk phosphorylates specific serine residues within cytosolic phospholipase A2 (PLA2), promoting enzyme translocation to membranes and facilitating liberation of arachidonic acid (AA). In the A549 human adenocarcinoma cell line dexamethasone inhibited epidermal growth factor (EGF)‐stimulated cytosolic PLA2 (cPLA2) activation and AA release by blocking the recruitment of Grb2 to the activated EGF receptor (EGF‐R) through a glucocorticoid receptor (GR)‐dependent (RU486‐sensitive), transcription‐independent (actinomycin‐insensitive), mechanism. The dexamethasone‐induced block of Grb2 recruitment was parallelled by changes in phosphorylation status and subcellular localization of lipocortin 1 (LC1) and an increase in the amount of the tyrosine phosphoprotein co‐localized with EGF‐R. Like dexamethasone, peptides containing E‐Q‐E‐Y‐V from the N‐terminal domain of LC1 also blocked ligand‐induced association of Grb2, p21ras and Raf. Our results point to an unsuspected rapid effect of glucocorticoids, mediated by occupation of GR but not by changes in gene transcription, which is brought about by competition between LC1 and Grb2 leading to a failure of recruitment off signalling factors to EGF‐R British Journal of Pharmacology (2000) 130, 289–298; doi:10.1038/sj.bjp.0703272</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>10807665</pmid><doi>10.1038/sj.bjp.0703272</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 2000-05, Vol.130 (2), p.289-298
issn 0007-1188
1476-5381
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1572055
source MEDLINE; Wiley Online Library Free Content; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects A549 cells
Adaptor Proteins, Signal Transducing
annexin 1
Annexin A1 - biosynthesis
Annexin A1 - metabolism
Binding, Competitive
Dexamethasone - pharmacology
Enzyme Activation
epidermal growth factor
epidermal growth factor receptors
glucocorticoids
Glucocorticoids - pharmacology
Grb2
GRB2 Adaptor Protein
Humans
Lipocortin 1
MAP Kinase Signaling System - physiology
mitogen‐activated protein kinase
phospholipase A2
Phospholipases A - metabolism
Phosphorylation - drug effects
Protein Conformation
Proteins - chemistry
Proteins - metabolism
Receptor, Epidermal Growth Factor - metabolism
Receptors, Glucocorticoid - metabolism
Signal Transduction - drug effects
Signal Transduction - physiology
Transcription, Genetic
Tumor Cells, Cultured
title Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor‐dependent, transcription‐independent mechanism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T19%3A37%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glucocorticoids%20act%20within%20minutes%20to%20inhibit%20recruitment%20of%20signalling%20factors%20to%20activated%20EGF%20receptors%20through%20a%20receptor%E2%80%90dependent,%20transcription%E2%80%90independent%20mechanism&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Croxtall,%20Jamie%20D&rft.date=2000-05&rft.volume=130&rft.issue=2&rft.spage=289&rft.epage=298&rft.pages=289-298&rft.issn=0007-1188&rft.eissn=1476-5381&rft_id=info:doi/10.1038/sj.bjp.0703272&rft_dat=%3Cproquest_pubme%3E1024061501%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=217177531&rft_id=info:pmid/10807665&rfr_iscdi=true